HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Murine cyclophilin-S1: a variant peptidyl-prolyl isomerase with a putative signal sequence expressed in differentiating F9 cells.

Abstract
Fractionation of differentiating murine teratocarcinoma F9 cells and extraction of the nuclear/microsomal pellets with ethidium bromide led to the purification and microsequencing of the protein mCyP-S1, a novel cyclosporin A-sensitive peptidyl-prolyl cis-trans isomerase (PPIase). mCyP-S1 is a new member of the cyclophilin class of proteins. Cloning and sequencing of the mCyP-S1 cDNA revealed extended coding capacity for a putative N-terminal signal sequence, suggesting processing of mCyP-S1 during intracellular translocation across the membrane of the endoplasmic reticulum. mCyP-S1 is abundantly expressed in a variety of mouse organ tissues and its mRNA levels increase during F9 cell differentiation. Specific subcellular localization of PPIases is postulated to contribute to functional specificities of this class of enzymes.
AuthorsA Schumacher, H Schröter, G Multhaup, A Nordheim
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1129 Issue 1 Pg. 13-22 (Dec 02 1991) ISSN: 0006-3002 [Print] Netherlands
PMID1756174 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carrier Proteins
  • Cyclosporins
  • Protein Sorting Signals
  • Amino Acid Isomerases
  • Cyclophilins
  • cyclophilin-S1
  • Peptidylprolyl Isomerase
Topics
  • Amino Acid Isomerases (genetics)
  • Amino Acid Sequence
  • Animals
  • Base Sequence
  • Blotting, Southern
  • Carrier Proteins (genetics)
  • Cell Differentiation (genetics)
  • Cloning, Molecular
  • Cyclophilins
  • Cyclosporins (genetics)
  • Gene Expression (genetics)
  • Mice (genetics)
  • Molecular Sequence Data
  • Peptidylprolyl Isomerase
  • Protein Sorting Signals (genetics)
  • Sequence Alignment
  • Sequence Homology, Nucleic Acid
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: